CEA, a complex glycoprotein that has long been established as a useful adjunct in monitoring patients with colorectal cancer (Goldstein and Mitchell, 2005), was investigated over a decade ago in patients with anal SCC undergoing combined chemoradiotherapy (Table 8) (Tanum et al, 1992). The gene discussed is CEACAM5; the disease is colorectal cancer.